AsperGenius® 2.0 Species (PN-101) y AsperGenius® 2.0 Resistance TR (PN-201)

Multiplex real‑time PCR assays for the detection and identification of Aspergillus species (PN-101) and azole resistance markers (PN-201) directly from clinical respiratory or blood samples.

Detailed Description

Invasive pulmonary aspergillosis (IPA) is a serious infection in immunocompromised individuals, caused mainly by Aspergillus fumigatus. Worldwide, more than 200,000 annual cases of IPA are recorded, and millions of people suffer from other forms of aspergillosis. Treatment is usually performed with azole antifungals, such as voriconazole, although resistance of A. fumigatus to these drugs has increased in the last decade, with prevalence rates of 1% to 20%. AsperGenius® 2.0 is an advanced diagnostic solution composed of two multiplex real‑time PCR kits, designed to support the rapid and accurate diagnosis of invasive aspergillosis (IA), as well as the detection of resistance to azole‑based antifungal treatments. • AsperGenius® 2.0 Species (PN-101): allows simultaneous identification of Aspergillus fumigatus, Aspergillus flavus, other Aspergillus species, and includes optional detection of A. terreus in a fifth channel. It analyzes the 28s region of ribosomal DNA, guaranteeing high specificity and sensitivity. • AsperGenius® 2.0 Resistance TR (PN-201): allows detection of the main genetic markers of azole resistance in A. fumigatus (TR34 and TR46), in addition to the wild‑type (WT) cyp51A gene. Both kits share an identical PCR protocol, facilitating simultaneous or sequential implementation in clinical laboratories. Results are obtained in approximately 1 hour after DNA extraction, favoring agile diagnosis that can positively impact the choice and speed of antifungal treatment. The system is validated for use with bronchoalveolar lavage (BAL), serum, and plasma samples, without the need for prior culture. This allows direct detection of the pathogen and its resistance mechanisms, which is key for timely therapeutic intervention in immunocompromised patients or those with suspected IA. The kits include internal and positive controls for each assay to ensure result reliability.

Key Features

Direct detection of Aspergillus spp. in BAL, serum or plasma without the need for culture
Specific differentiation of A. fumigatus, A. flavus and A. terreus
Detection of azole resistance (TR34 and TR46 in A. fumigatus)
Multiplex assays with unified protocol for both tests
Approximate PCR time: 1 hour
Validated on clinical samples and External Quality Control programs (QCMD)
Include internal and positive controls
Certified for in vitro diagnostic use (CE-IVD)
Enable rapid and targeted optimization of antifungal treatment

Presentation Details

AsperGenius® 2.0 Species (PN-101)
Content: 50 reactions Targets: Aspergillus fumigatus, Aspergillus flavus, Aspergillus terreus (only on Rotor-Gene Q and CFX96), other Aspergillus species, and internal control
AsperGenius® 2.0 Resistance TR (PN-201)
Content: 50 reactions Targets: TR34, TR46, wild‑type (WT) cyp51A of A. fumigatus, and internal control
Additional Information
Compatible instruments: LightCycler® 480 II, Rotor-Gene® Q, CFX96, QuantStudio™ 5, Mic qPCR cycler Compatible samples: bronchoalveolar lavage (BAL), serum, plasma Recommended DNA extraction: NucliSENS® easyMAG® (bioMérieux), QIAamp MinElute Virus Spin kit (QIAGEN) Certification: CE-IVD Manufacturer: PathoNostics B.V. (Netherlands)
×

Area:

Fungus, Microbiology

Documents:

Consult our experts

Google reCaptcha: Invalid site key.

Related products

Sepsis Pathogenic Microorganism Detection Kit (Digital PCR)

In vitro diagnostic kit based on droplet digital PCR (dPCR) for the detection of pathogenic microorganisms associated with sepsis from DNA extracted from clinical samples. The kit allows identification and quantification of pathogens without requiring blood culture, covering 21 frequent agents in bloodstream infections. Detailed Description Principle of operation The Sepsis Pathogenic Microorganism Detection Kit…
RainSure
Digital PCR

VIASURE 16S V1-V4 NGS Solution

NGS solution for library preparation aimed at the simultaneous identification and profiling of microbial species present in DNA extracted from original samples, through the analysis of the variable regions V1-V4 of the 16S rRNA gene. Product for research use only (RUO) and not intended for diagnostic procedures. Detailed Description Principle of operation VIASURE 16S V1-V4…
Certest
Next Generation Sequencing (NGS)

PN-900 CandidaGenius® C. auris screening assay

Real‑time PCR assay for the rapid and direct detection of Candida auris from non‑invasive swabs, without the need for prior culture. Detailed Description The PN-900 CandidaGenius® C. auris screening assay is a molecular tool designed for the qualitative detection of Candida auris DNA by real‑time PCR. This emerging fungus represents a growing challenge in the…
Pathonostics
Real Time PCR (qPCR)

Illumina Viral Surveillance Panel v2

Next‑generation sequencing (NGS) assay with hybrid capture enrichment for the detection and whole‑genome sequencing of approximately 200 RNA and DNA viruses relevant to public health. It integrates library preparation, enrichment, sequencing, and data analysis into an optimized workflow of about two days. Detailed Description Principle of operation The panel can start from RNA, DNA, or…
Illumina
Next Generation Sequencing (NGS)